Showing posts with label insomnia. Show all posts
Showing posts with label insomnia. Show all posts
Wednesday, March 9, 2022

FDA Approves Quviviq (daridorexant) for the Treatment of Adults with Insomnia

›
Idorsia Ltd (SIX: IDIA) announced  the US Food and Drug Administration (FDA)  approval of   Quviviq  (daridorexant) 25 mg and 50 mg for the ...
Wednesday, June 24, 2020

Suvorexant May Improve Insomnia With Alzheimer Disease

›
In continuation of my update on  Suvorexant Suvorexant improves total sleep time (TST) in patients with probable Alzheimer disease...
Monday, May 13, 2019

Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia

›
In continuation of my update on  lemborexant Eisai Co., Ltd. (CEO: Haruo Naito, “Eisai”) and Imbrium Therapeutics L.P. (Imbriu...
Thursday, July 25, 2013

Merck Receives Complete Response Letter for Suvorexant, Merck’s Investigational Medicine for Insomnia

›
In continuation of my update on Suvorexant
Wednesday, December 12, 2012

Drug offers alternative treatment strategy for insomnia

›
In continuation of my update on   suvorexant The team, led by W Joseph Herring (Merck Sharp & Dohme Corp, Whitehouse Station, Ne...
Sunday, August 26, 2012

Insomnia Drug Closer to Approval | News | Drug Discovery and Development Magazine

›
Merck & Co. said that its experimental insomnia drug suvorexant (see structure) helped patients fall asleep faster and stay asleep ...
Saturday, November 26, 2011

FDA Approves Intermezzo.....

›
The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomn...